David Vera

Title(s)Adjunct Professor, Radiology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, DavisPh.D. degree in Biophysics
    University of California, San FranciscoB.S. degree in BiologySchool of Medicine

    Collapse Research 
    Collapse Research Activities and Funding
    Renal Molecular Imaging of Mesangial Cell Function with Tc-99m-Tilmanocept
    NIH R01DK127201Apr 1, 2021 - Feb 28, 2024
    Role: Co-Principal Investigator
    MR Solutions Benchtop Cryogen Free Superconducting 1.5T/3.0T Rodent MR Scanner
    NIH S10OD018225Apr 17, 2015 - Oct 16, 2016
    Role: Co-Principal Investigator
    In Vivo Cellular and Molecular Imaging Centers (ICMICs)
    NIH P50CA128346Sep 23, 2008 - Aug 31, 2014
    Role: Principal Investigator
    In Vivo Cellular and Molecular Imaging Centers (ICMICs)
    NIH P20CA134224Sep 28, 2007 - Aug 31, 2009
    Role: Principal Investigator
    Workshop on Molecular Imaging Agents
    NIH R13CA126365Apr 1, 2007 - Mar 31, 2008
    Role: Principal Investigator
    Size-Dependent Uptake of Tc(I)-Labeled RGD Analogs
    NIH R41CA112797Jan 12, 2005 - Dec 31, 2006
    Role: Principal Investigator
    Workshop on Receptor-Binding Radiotracers 2003
    NIH R13CA101304Feb 10, 2003 - Jan 31, 2004
    Role: Principal Investigator
    BLOOD POOL CONTRAST AGENTS FOR CT AND MRI
    NIH R01EB002111Apr 1, 2000 - Mar 31, 2005
    Role: Principal Investigator
    BLOOD POOL CONTRAST AGENTS FOR CT AND MRI
    NIH R01CA082335Apr 1, 2000 - Mar 31, 2004
    Role: Principal Investigator
    RECEPTOR BINDING RADIOTRACER FOR SENTINEL NODE IMAGING
    NIH R01CA072751Feb 1, 1997 - Jan 31, 2002
    Role: Principal Investigator
    RECEPTOR-BASED RADIOTRACERS FOR CARDIOVASCULAR IMAGING
    NIH R01HL035346Dec 1, 1985 - Nov 30, 1986
    Role: Principal Investigator
    VALIDATION OF A KINETIC MODEL FOR RECEPTOR IMAGING
    NIH R01DK034768Dec 1, 1984 - Mar 31, 1996
    Role: Principal Investigator
    VALIDATION OF A KINETIC MODEL FOR RECEPTOR IMAGING
    NIH R23AM034768Dec 1, 1984 - Nov 30, 1985
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A novel method for tracking nitrogen kinetics in vivo under hyperbaric conditions using radioactive nitrogen-13 gas and positron emission tomography. J Appl Physiol (1985). 2024 Apr 01; 136(4):949-953. Ashworth ET, Ogawa R, Nguyen J, Afif C, Sá RC, Butts Pauly K, Vera DR, Lindholm P. PMID: 38420678; PMCID: PMC11305641.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    2. Effects of oxygen-prebreathing on tissue nitrogenation in normobaric and hyperbaric conditions. PLoS One. 2024; 19(1):e0294611. Ashworth ET, Ogawa R, Vera DR, Lindholm P. PMID: 38252649; PMCID: PMC10802958.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    3. Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection. PLoS Pathog. 2023 09; 19(9):e1011487. Aguilar-Calvo P, Malik A, Sandoval DR, Barback C, Orrù CD, Standke HG, Thomas OR, Dwyer CA, Pizzo DP, Bapat J, Soldau K, Ogawa R, Riley MB, Nilsson KPR, Kraus A, Caughey B, Iliff JJ, Vera DR, Esko JD, Sigurdson CJ. PMID: 37747931; PMCID: PMC10586673.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    4. Fluorescent Guided Sentinel Lymph Mapping of the Oral Cavity with Fluorescent-Labeled Tilmanocept. Laryngoscope. 2024 03; 134(3):1299-1307. Guo T, Jang SS, Ogawa R, Davis M, Ashworth E, Barback CV, Hall DJ, Vera DR. PMID: 37668315; PMCID: PMC10912359.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    5. The kidney drug transporter OAT1 regulates gut microbiome-dependent host metabolism. JCI Insight. 2023 01 24; 8(2). Granados JC, Ermakov V, Maity K, Vera DR, Chang G, Nigam SK. PMID: 36692015; PMCID: PMC9977316.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    6. Role of sentinel lymph node biopsy for oral squamous cell carcinoma: Current evidence and future challenges. Head Neck. 2023 Jan; 45(1):251-265. Jang SS, Davis ME, Vera DR, Lai SY, Guo TW. PMID: 36193862; PMCID: PMC11081060.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. MicroPET evidence for a hypersensitive neuroinflammatory profile of gp120 mouse model of HIV. Psychiatry Res Neuroimaging. 2022 04; 321:111445. Young JW, Barback CV, Stolz LA, Groman SM, Vera DR, Hoh C, Kotta KK, Minassian A, Powell SB, Brody AL. PMID: 35101828.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    8. Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal. Sci Adv. 2020 06; 6(26):eaba4353. Svensson MND, Zoccheddu M, Yang S, Nygaard G, Secchi C, Doody KM, Slowikowski K, Mizoguchi F, Humby F, Hands R, Santelli E, Sacchetti C, Wakabayashi K, Wu DJ, Barback C, Ai R, Wang W, Sims GP, Mydel P, Kasama T, Boyle DL, Galimi F, Vera D, Tremblay ML, Raychaudhuri S, Brenner MB, Firestein GS, Pitzalis C, Ekwall AH, Stanford SM, Bottini N. PMID: 32637608; PMCID: PMC7319753.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    9. Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation. Nucl Med Biol. 2021 Jan; 92:5-23. Krohn KA, Vera DR. PMID: 32331709; PMCID: PMC8049838.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    10. A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept. Nucl Med Biol. 2021 Jan; 92:107-114. Chen W, Barback CV, Wang S, Hoh CK, Chang EY, Hall DJ, Head BP, Vera DR. PMID: 32169304.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    11. Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept. J Nucl Med. 2019 09; 60(9):1325-1332. Qin Z, Hoh CK, Olson ES, Jahromi AH, Hall DJ, Barback CV, You YH, Yanagita M, Sharma K, Vera DR. PMID: 30796169; PMCID: PMC6910642.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    12. Next generation of radiotracers for sentinel lymph node biopsy: What is still necessary to establish new imaging paradigms? Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Nov - Dec; 37(6):373-379. Vidal-Sicart S, Vera DR, Valdés Olmos RA. PMID: 30409688.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. Effect of overnight smoking abstinence on a marker for microglial activation: a [11C]DAA1106 positron emission tomography study. Psychopharmacology (Berl). 2018 Dec; 235(12):3525-3534. Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, Kotta KK, London ED, Okita K, Nurmi EL, Seaman LC, Mandelkern MA. PMID: 30343364; PMCID: PMC6497451.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    14. Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model. PLoS One. 2018; 13(7):e0197842. Anderson KM, Barback CV, Qin Z, Hall DJ, Hoh CK, Vera DR, McHale MT. PMID: 29965996; PMCID: PMC6028102.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    15. Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept. EJNMMI Res. 2017 Dec; 7(1):40. Varasteh Z, Hyafil F, Anizan N, Diallo D, Aid-Launais R, Mohanta S, Li Y, Braeuer M, Steiger K, Vigne J, Qin Z, Nekolla SG, Fabre JE, Döring Y, Le Guludec D, Habenicht A, Vera DR, Schwaiger M. PMID: 28470406; PMCID: PMC5415447.
      View in: PubMed   Mentions: 19  
    16. Fluorescence-Based Molecular Imaging of Porcine Urinary Bladder Sentinel Lymph Nodes. J Nucl Med. 2017 04; 58(4):547-553. Lee HJ, Barback CV, Hoh CK, Qin Z, Kader K, Hall DJ, Vera DR, Kane CJ. PMID: 28153955; PMCID: PMC6945107.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    17. Assessment of in vivo systemic toxicity and biodistribution of iron-doped silica nanoshells. Nanomedicine. 2017 04; 13(3):933-942. Mendez N, Liberman A, Corbeil J, Barback C, Viveros R, Wang J, Wang-Rodriguez J, Blair SL, Mattrey R, Vera D, Trogler W, Kummel AC. PMID: 27840314.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    18. New Dioxaborolane Chemistry Enables [(18)F]-Positron-Emitting, Fluorescent [(18)F]-Multimodality Biomolecule Generation from the Solid Phase. Bioconjug Chem. 2016 05 18; 27(5):1390-1399. Rodriguez EA, Wang Y, Crisp JL, Vera DR, Tsien RY, Ting R. PMID: 27064381; PMCID: PMC4916912.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    19. Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. Nucl Med Biol. 2016 Feb; 43(2):179-87. Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera DR. PMID: 26872443.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    20. Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S559-65. Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, Wallace AM. PMID: 26275779; PMCID: PMC4686557.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    21. A tri-modal molecular imaging agent for sentinel lymph node mapping. Nucl Med Biol. 2015 Dec; 42(12):917-22. Qin Z, Hoh CK, Hall DJ, Vera DR. PMID: 26320812.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    22. γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206). J Immunol. 2015 Sep 01; 195(5):2019-29. Azad AK, Rajaram MV, Metz WL, Cope FO, Blue MS, Vera DR, Schlesinger LS. PMID: 26202986; PMCID: PMC4543904.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    23. Sentinel lymph node biopsy in bladder cancer: Systematic review and technology update. Indian J Urol. 2015 Jul-Sep; 31(3):170-5. Liss MA, Noguchi J, Lee HJ, Vera DR, Kader AK. PMID: 26166959; PMCID: PMC4495490.
      View in: PubMed   Mentions: 3  
    24. Robotic-assisted fluorescence sentinel lymph node mapping using multimodal image guidance in an animal model. Urology. 2014 Oct; 84(4):982.e9-14. Liss MA, Stroup SP, Qin Z, Hoh CK, Hall DJ, Vera DR, Kane CJ. PMID: 25139676; PMCID: PMC4366424.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    25. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients. Ann Surg Oncol. 2015 Jan; 22(1):40-5. Baker JL, Pu M, Tokin CA, Hoh CK, Vera DR, Messer K, Wallace AM. PMID: 25069859; PMCID: PMC4273083.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    26. Preclinical evaluation of robotic-assisted sentinel lymph node fluorescence imaging. J Nucl Med. 2014 Sep; 55(9):1552-6. Liss MA, Farshchi-Heydari S, Qin Z, Hickey SA, Hall DJ, Kane CJ, Vera DR. PMID: 25024425; PMCID: PMC4350927.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    27. Fluorescent-tilmanocept for tumor margin analysis in the mouse model. J Surg Res. 2014 Aug; 190(2):528-34. Hosseini A, Baker JL, Tokin CA, Qin Z, Hall DJ, Stupak DG, Hayashi T, Wallace AM, Vera DR. PMID: 24923630; PMCID: PMC4201840.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    28. Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom. Phys Med Biol. 2014 Jun 07; 59(11):2727-46. Lajtos I, Czernin J, Dahlbom M, Daver F, Emri M, Farshchi-Heydari S, Forgacs A, Hoh CK, Joszai I, Krizsan AK, Lantos J, Major P, Molnar J, Opposits G, Tron L, Vera DR, Balkay L. PMID: 24800813.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    29. 68Ga chelating bioorthogonal tetrazine polymers for the multistep labeling of cancer biomarkers. Chem Commun (Camb). 2014 May 25; 50(40):5215-5217. Nichols B, Qin Z, Yang J, Vera DR, Devaraj NK. PMID: 24589653; PMCID: PMC4119763.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    30. Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes. J Biomed Opt. 2013 Oct; 18(10):101315. Qin Z, Hall DJ, Liss MA, Hoh CK, Kane CJ, Wallace AM, Vera DR. PMID: 23958947; PMCID: PMC3745642.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    31. Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells. ACS Nano. 2013 Jul 23; 7(7):6367-77. Liberman A, Wu Z, Barback CV, Viveros R, Blair SL, Ellies LG, Vera DR, Mattrey RF, Kummel AC, Trogler WC. PMID: 23802554; PMCID: PMC3777724.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    32. Development of ⁶⁸Ga-labelled DTPA galactosyl human serum albumin for liver function imaging. Eur J Nucl Med Mol Imaging. 2013 Aug; 40(8):1245-55. Haubner R, Vera DR, Farshchi-Heydari S, Helbok A, Rangger C, Putzer D, Virgolini IJ. PMID: 23579865.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    33. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials. Ann Surg Oncol. 2013 Aug; 20(8):2590-9. Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR. PMID: 23504141; PMCID: PMC3705144.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    34. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology. 2012 Oct; 265(1):186-93. Emerson DK, Limmer KK, Hall DJ, Han SH, Eckelman WC, Kane CJ, Wallace AM, Vera DR. PMID: 22753678; PMCID: PMC3447170.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    35. The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of care. Clin Exp Metastasis. 2012 Oct; 29(7):681-6. Tokin CA, Cope FO, Metz WL, Blue MS, Potter BM, Abbruzzese BC, Hartman RD, Joy MT, King DW, Christman LA, Vera DR, Wallace AM. PMID: 22729510.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    36. Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model. Clin Exp Metastasis. 2012 Oct; 29(7):673-80. Stroup SP, Kane CJ, Farchshchi-Heydari S, James CM, Davis CH, Wallace AM, Hoh CK, Vera DR. PMID: 22714690.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    37. Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjug Chem. 2010 Oct 20; 21(10):1811-9. Ting R, Aguilera TA, Crisp JL, Hall DJ, Eckelman WC, Vera DR, Tsien RY. PMID: 20873712; PMCID: PMC2957852.
      View in: PubMed   Mentions: 39     Fields:    Translation:Animals
    38. Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. Nucl Med Biol. 2009 Aug; 36(6):687-92. Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera DR. PMID: 19647175; PMCID: PMC4201841.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    39. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts. Cancer Chemother Pharmacol. 2010 Feb; 65(3):515-26. Wang X, Zhao G, Van S, Jiang N, Yu L, Vera D, Howell SB. PMID: 19593566; PMCID: PMC2797414.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    40. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci U S A. 2009 Jul 07; 106(27):11137-42. Shackelford DB, Vasquez DS, Corbeil J, Wu S, Leblanc M, Wu CL, Vera DR, Shaw RJ. PMID: 19541609; PMCID: PMC2708689.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansAnimalsCells
    41. Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function. Am J Physiol Renal Physiol. 2009 Jul; 297(1):F210-7. Wu W, Kitamura S, Truong DM, Rieg T, Vallon V, Sakurai H, Bush KT, Vera DR, Ross RS, Nigam SK. PMID: 19439520; PMCID: PMC2711709.
      View in: PubMed   Mentions: 39     Fields:    Translation:Animals
    42. After bench to bedside: the impact of disease progression, commercial opportunities and available instrumentation on clinical outcome. Nucl Med Biol. 2007 Oct; 34(7):727-8. Eckelman WC, Vera DR. PMID: 17921023.
      View in: PubMed   Mentions: 1     Fields:    
    43. Sentinel lymph node mapping of breast cancer via intradermal administration of Lymphoseek. Nucl Med Biol. 2007 Oct; 34(7):849-53. Wallace AM, Hoh CK, Darrah DD, Schulteis G, Vera DR. PMID: 17921035; PMCID: PMC4189800.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    44. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET. Nucl Med Commun. 2007 Jan; 28(1):7-13. Obrzut S, Pham RH, Vera DR, Badran K, Hoha CK. PMID: 17159543.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    45. Lymphoseek: a molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol. 2007 Feb; 14(2):913-21. Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR. PMID: 17146742.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    46. Molecular targeting of the lymphovascular system for imaging and therapy. Cancer Metastasis Rev. 2006 Jun; 25(2):185-201. Schöder H, Glass EC, Pecking AP, Harness JK, Wallace AM, Hirnle P, Alberini JL, Vilain D, Larson SM, Hoh CK, Vera DR. PMID: 16770532.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCTClinical Trials
    47. A preclinical study of prostate sentinel lymph node mapping with [99mTC]diethylenetetramine pentaacetic acid-mannosyl-dextran. J Urol. 2006 Feb; 175(2):744-8. Salem CE, Hoh CK, Wallace AM, Vera DR. PMID: 16407043.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    48. Minimally invasive sentinel lymph node mapping of the pig colon with Lymphoseek. Surgery. 2006 Feb; 139(2):217-23. Wallace AM, Ellner SJ, Méndez J, Hoh CK, Salem CE, Bosch CM, Orahood RC, Vera DR. PMID: 16455331.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    49. What is to be gained by imaging the same animal before and after treatment? Nucl Med Biol. 2005 Oct; 32(7):727-32. Scheibe PO, Vera DR, Eckelman WC. PMID: 16243648.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    50. Breast imaging: a surgeon's prospective. Nucl Med Biol. 2005 Oct; 32(7):781-92. Wallace AM, Comstock C, Hoh CK, Vera DR. PMID: 16243654.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry. Nucl Med Biol. 2005 Oct; 32(7):687-93. Vera DR, Hall DJ, Hoh CK, Gallant P, McIntosh LM, Mattrey RF. PMID: 16243643.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    52. Are there lessons to be learned from drug development that will accelerate the use of molecular imaging probes in the clinic? Nucl Med Biol. 2005 Oct; 32(7):657-62. Eckelman WC, Rohatagi S, Krohn KA, Vera DR. PMID: 16243639.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    53. Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad Radiol. 2004 Dec; 11(12):1361-9. Sirlin CB, Vera DR, Corbeil JA, Caballero MB, Buxton RB, Mattrey RF. PMID: 15596374.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    54. Sentinel lymph node mapping of the colon and stomach using lymphoseek in a pig model. Ann Surg Oncol. 2004 Jul; 11(7):674-81. Ellner SJ, Méndez J, Vera DR, Hoh CK, Ashburn WL, Wallace AM. PMID: 15231522.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    55. Clinical application of TcGSA. Nucl Med Biol. 2003 Nov; 30(8):845-9. Kokudo N, Vera DR, Makuuchi M. PMID: 14698788.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    56. From bench to bedside. Nucl Med Biol. 2003 Nov; 30(8):793-4. Eckelman WC, Vera DR. PMID: 14698781.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    57. Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping. Nucl Med Biol. 2003 Nov; 30(8):805-10. Ellner SJ, Hoh CK, Vera DR, Darrah DD, Schulteis G, Wallace AM. PMID: 14698783.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    58. Detection of gastric and colonic sentinel nodes through endoscopic administration of 99mTc-DTPA-mannosyl-dextran in pigs. J Nucl Med. 2003 Oct; 44(10):1677-81. Méndez J, Wallace AM, Hoh CK, Vera DR. PMID: 14530486.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    59. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran . Nucl Med Biol. 2003 Jul; 30(5):457-64. Hoh CK, Wallace AM, Vera DR. PMID: 12831982.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsPHPublic Health
    60. Lymphoseek: a molecular radiopharmaceutical for sentinel node detection. Ann Surg Oncol. 2003 Jun; 10(5):531-8. Wallace AM, Hoh CK, Vera DR, Darrah DD, Schulteis G. PMID: 12794019.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCellsCTClinical Trials
    61. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg. 2002 Nov; 26(11):1342-7. Kokudo N, Vera DR, Tada K, Koizumi M, Seki M, Matsubara T, Ohta H, Yamaguchi T, Takahashi T, Nakajima T, Muto T. PMID: 12297928.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    62. A molecular CT blood pool contrast agent. Acad Radiol. 2002 Jul; 9(7):784-92. Vera DR, Mattrey RF. PMID: 12139092.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    63. [(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection. Nucl Med Biol. 2001 Jul; 28(5):493-8. Vera DR, Wallace AM, Hoh CK. PMID: 11516693.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    64. Receptor 1980 and Receptor 2000: twenty years of progress in receptor-binding radiotracers. Nucl Med Biol. 2001 Jul; 28(5):475-6. Vera DR, Eckelman WC. PMID: 11516690.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    65. The evolution of (99m)Tc-NGA as a clinically useful receptor-binding radiopharmaceutical. Nucl Med Biol. 2001 Jul; 28(5):499-503. Stadalnik RC, Vera DR. PMID: 11516694.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    66. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran. J Nucl Med. 2001 Jun; 42(6):951-9. Vera DR, Wallace AM, Hoh CK, Mattrey RF. PMID: 11390562.
      View in: PubMed   Mentions: 52     Fields:    Translation:Animals
    67. Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. J Nucl Med. 2001 May; 42(5):733-7. Miki K, Kubota K, Inoue Y, Vera DR, Makuuchi M. PMID: 11337568.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    68. Portal-Systemic shunts reduce asialoglycoprotein receptor density in rats. J Nucl Med. 2001 Jan; 42(1):110-6. Colquhoun SD, Connelly CA, Vera DR. PMID: 11197958.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    69. TIPS reduces hepatic asialoglycoprotein receptor concentration in healthy pigs. J Vasc Interv Radiol. 2000 Jan; 11(1):123-8. Stein M, Vera DR, Stadalnik RC. PMID: 10693724.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    70. Blue dye and 99mTc-labeled human serum albumin: sentinel node detection by magic bullets? J Nucl Med. 1999 Jul; 40(7):1149-50. Wallace AM, Vera DR, Stadalnik RC. PMID: 10405135.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Recovery of hepatic asialoglycoprotein receptors after major hepatic resection. J Nucl Med. 1999 Jan; 40(1):137-41. Kokudo N, Vera DR, Koizumi M, Seki M, Sato T, Stadalnik RC, Takahashi T. PMID: 9935069.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    72. Sentinel node imaging via a nonparticulate receptor-binding radiotracer. J Nucl Med. 1997 Apr; 38(4):530-5. Vera DR, Wisner ER, Stadalnik RC. PMID: 9098197.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    73. Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry. J Nucl Med. 1996 Nov; 37(11):1896-902. Xu JC, Vera DR, Stadalnik RC. PMID: 8917199.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Diagnostic performance of a receptor-binding radiopharmacokinetic model. J Nucl Med. 1996 Jan; 37(1):160-4. Vera DR, Stadalnik RC, Metz CE, Pimstone NR. PMID: 8543988.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    75. Tumor imaging with a macromolecular paramagnetic contrast agent: gadopentetate dimeglumine-polylysine. Acad Radiol. 1995 Sep; 2(9):762-7. Opsahl LR, Uzgiris EE, Vera DR. PMID: 9419637.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    76. A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver. Acad Radiol. 1995 Jun; 2(6):497-506. Vera DR, Buonocore MH, Wisner ER, Katzberg RW, Stadalnik RC. PMID: 9419597.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    77. Arabinogalactan-coated superparamagnetic iron oxide: effect of particle size in liver MRI. J Comput Assist Tomogr. 1995 Mar-Apr; 19(2):211-5. Wisner ER, Amparo EG, Vera DR, Brock JM, Barlow TW, Griffey SM, Drake C, Katzberg RW. PMID: 7890843.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    78. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology. 1994 Oct; 20(4 Pt 1):917-23. Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL. PMID: 7927233.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    79. Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty. IEEE Trans Biomed Eng. 1994 Sep; 41(9):891-7. Vera DR, Scheibe PO, Banin Y, Stadalnik RC. PMID: 7959816.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. In vivo quantification of asialoglycoprotein receptor. Methods Enzymol. 1994; 247:373-82. Kudo M, Vera DR, Stadalnik RC. PMID: 7898365.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. In vitro quantification of asialoglycoprotein receptor density from human hepatic microsamples. Methods Enzymol. 1994; 247:394-402. Vera DR, Topcu SJ, Stadalnik RC. PMID: 7898367.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    82. Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin. Methods Enzymol. 1994; 247:402-9. Vera DR, Stadalnik RC, Kudo M, Krohn KA. PMID: 7898368.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    83. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin. Dig Dis Sci. 1993 Dec; 38(12):2183-8. Kudo M, Vera DR, Stadalnik RC, Esquivel CO, Trudeau WL, Ikekubo K, Todo A. PMID: 8261818.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology. 1993 May; 17(5):814-9. Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC. PMID: 8491449.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    85. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model. Invest Radiol. 1993 Jan; 28(1):64-70. Stadalnik RC, Kudo M, Eckelman WC, Vera DR. PMID: 8425855.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    86. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry. J Nucl Med. 1992 Jun; 33(6):1160-6. Vera DR. PMID: 1597732.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    87. Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng. 1992 Apr; 39(4):356-67. Vera DR, Scheibe PO, Krohn KA, Trudeau WL, Stadalnik RC. PMID: 1592401.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    88. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model. J Nucl Med. 1991 Jun; 32(6):1177-82. Kudo M, Vera DR, Trudeau WL, Stadalnik RC. PMID: 2045931.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    89. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. J Nucl Med. 1991 Jun; 32(6):1169-76. Vera DR, Stadalnik RC, Trudeau WL, Scheibe PO, Krohn KA. PMID: 2045930.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    90. [In vivo measurement of hepatic binding protein in chronic liver disease--validation as a measure of hepatic functional reserve]. Nihon Shokakibyo Gakkai Zasshi. 1991 Jan; 88(1):40-50. Kudo M, Vera DR, Stadalnik RC, Trudeau WL, Ikekubo K, Todo A. PMID: 1851238.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    91. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity. Int J Rad Appl Instrum B. 1991; 18(7):663-6. Kudo M, Vera DR, Trudeau WL, Stadalnik RC. PMID: 1787074.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    92. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve. Am J Gastroenterol. 1990 Sep; 85(9):1142-8. Kudo M, Vera DR, Stadalnik RC, Trudeau WL, Ikekubo K, Todo A. PMID: 2389727.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    93. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin. J Nucl Med. 1989 Sep; 30(9):1519-30. Vera DR, Woodle ES, Stadalnik RC. PMID: 2549225.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    94. Tc-NGA imaging in liver transplantation: preliminary clinical experience. Surgery. 1989 Mar; 105(3):401-7. Woodle ES, Ward RE, Stadalnik RC, Vera DR. PMID: 2646744.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Tc-NGA imaging in liver transplantation: preclinical studies. Surgery. 1987 Jul; 102(1):55-62. Woodle ES, Vera DR, Stadalnik RC, Ward RE. PMID: 3296267.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    96. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med. 1985 Nov; 26(11):1233-42. Stadalnik RC, Vera DR, Woodle ES, Trudeau WL, Porter BA, Ward RE, Krohn KA, O'Grady LF. PMID: 2997417.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    97. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies. J Nucl Med. 1985 Oct; 26(10):1157-67. Vera DR, Stadalnik RC, Krohn KA. PMID: 4045560.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    98. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system. IEEE Trans Biomed Eng. 1985 May; 32(5):312-22. Vera DR, Krohn KA, Scheibe PO, Stadalnik RC. PMID: 3997184.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    99. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding. J Nucl Med. 1984 Jul; 25(7):779-87. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. PMID: 6737077.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    100. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes. Radiology. 1984 Apr; 151(1):191-6. Vera DR, Krohn KA, Stadalnik RC, Scheibe PO. PMID: 6701314.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    101. Clinical experience with 99mTc-disofenin as a cholescintigraphic agent. Radiology. 1981 Sep; 140(3):797-800. Stadalnik RC, Matolo NM, Jansholt AL, Vera DR. PMID: 7025091.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    David's Networks
    Concepts (380)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (47)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California